GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
2.850
+0.050 (1.79%)
Jun 29, 2026, 4:00 PM EDT - Market closed
GoodRx Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 787.89 | 796.85 | 792.32 | 750.27 | 766.55 | 745.42 | |
Revenue Growth (YoY) | -1.19% | 0.57% | 5.61% | -2.13% | 2.83% | 35.36% |
Cost of Revenue | 64.39 | 57.6 | 48.22 | 66.93 | 65.08 | 46.72 |
Gross Profit | 723.5 | 739.26 | 744.11 | 683.34 | 701.48 | 698.71 |
Selling, General & Admin | 439.22 | 445.52 | 484.98 | 466.84 | 502.42 | 524.9 |
Depreciation & Amortization Expenses | 86.1 | 85.22 | 69.54 | 107.67 | 54.18 | 34.54 |
Research & Development | 120.06 | 121.03 | 123.75 | 135.84 | 143.14 | 125.86 |
Total Operating Expenses | 645.38 | 651.76 | 678.26 | 710.35 | 699.74 | 685.3 |
Operating Income | 78.12 | 87.49 | 65.85 | -27.01 | 1.74 | 13.41 |
Interest Income | 8.4 | 10.93 | 23.27 | 32.17 | 9.27 | 0.06 |
Interest Expense | -41.73 | -42.61 | -52.92 | -56.73 | -34.24 | -23.64 |
Other Non-Operating Income (Expense) | 0.72 | 0.72 | -4.74 | -4.01 | - | - |
Total Non-Operating Income (Expense) | 32.61 | 30.95 | 34.39 | 28.57 | 24.97 | 23.58 |
Pretax Income | 45.51 | 56.54 | 31.46 | -55.57 | -23.23 | -10.18 |
Provision for Income Taxes | 24.95 | 26.1 | 15.07 | -46.7 | 9.6 | 15.08 |
Net Income | 20.56 | 30.44 | 16.39 | -8.87 | -32.83 | -25.25 |
Net Income to Common | 20.56 | 30.44 | 16.39 | -8.87 | -32.83 | -25.25 |
Net Income Growth | -27.75% | 85.72% | - | - | - | - |
Shares Outstanding (Basic) | 346 | 356 | 386 | 410 | 413 | 410 |
Shares Outstanding (Diluted) | 347 | 357 | 392 | 410 | 413 | 410 |
Shares Change (YoY) | -9.72% | -8.97% | -4.42% | -0.62% | 0.70% | 49.25% |
EPS (Basic) | 0.06 | 0.09 | 0.04 | -0.02 | -0.08 | -0.06 |
EPS (Diluted) | 0.06 | 0.09 | 0.04 | -0.02 | -0.08 | -0.06 |
EPS Growth | -25.00% | 125.00% | - | - | - | - |
Free Cash Flow | 165.81 | 164.38 | 182.65 | 137.25 | 142.81 | 174.21 |
Free Cash Flow Growth | 0.87% | -10.00% | 33.08% | -3.90% | -18.02% | 57.24% |
Free Cash Flow Per Share | 0.48 | 0.46 | 0.47 | 0.33 | 0.35 | 0.42 |
Gross Margin | 91.83% | 92.77% | 93.91% | 91.08% | 91.51% | 93.73% |
Operating Margin | 9.92% | 10.98% | 8.31% | -3.60% | 0.23% | 1.80% |
Profit Margin | 2.61% | 3.82% | 2.07% | -1.18% | -4.28% | -3.39% |
FCF Margin | 21.05% | 20.63% | 23.05% | 18.29% | 18.63% | 23.37% |
EBITDA | 164.22 | 172.71 | 135.38 | 80.66 | 55.92 | 47.95 |
EBITDA Margin | 20.84% | 21.67% | 17.09% | 10.75% | 7.29% | 6.43% |
EBIT | 78.12 | 87.49 | 65.85 | -27.01 | 1.74 | 13.41 |
EBIT Margin | 9.92% | 10.98% | 8.31% | -3.60% | 0.23% | 1.80% |
Effective Tax Rate | 54.83% | 46.16% | 47.90% | 84.04% | -41.31% | -148.15% |